Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	3.97	17.65	16.97
Graham Fair Price	-9.09	4.06	4.47
PEG	0.00	0.00	0.00
Price/Book	-5.49	1.84	1.95
Price/Cash Flow	-94.35	-11.67	206.60
Prices/Earnings	28.85	7.07	5.49
Price/Sales	7.71	2.30	2.13
Price/FCF	-94.35	-11.67	206.60
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	57.35	0.42	0.27
Operating Margin	24.70	0.16	0.13
ROA	-41.52	0.02	0.04
ROE	0.09	0.07	-26.65
ROIC	0.04	0.04	4.38
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	0.00	0.00	0.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.91	0.00	inf
EPS QOQ	0.00	0.00	0.00
FCF QOQ	-0.46	0.00	inf
Revenue QOQ	0.93	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	82.52	93.37	13.15
Days Sales Outstanding (DSO)	99.52	137.14	37.81
Inventory Turnover	1.09	0.96	-11.62
Debt/Capitalization	0.54	0.56	3.32
Quick Ratio	1.29	2.53	97.02
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	3.16	3.36	6.15
Cash	0.47	2.04	337.22
Capex	-0.21	-0.12	42.58
Free Cash Flow	0.03	-0.53	1675.49
Revenue	2.89	2.69	-6.85
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	2.13	3.40	59.60
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.52	5.96	69.23
Naive Interpretation	Member

06 - Financial Health · Bad

Rating